Atlas Trials

A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer Pain

Clinical trial NCT03967327 · UNKNOWN

Trial details

NCT number
NCT03967327
Sponsor
Mundipharma (China) Pharmaceutical Co. Ltd
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Cancer Pain
Start date
2019-04-22
Primary completion
2020-12-20
Enrollment
194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.